Implementation Guidelines - Federal Transit Administration - U.S. ...
Implementation Guidelines - Federal Transit Administration - U.S. ... Implementation Guidelines - Federal Transit Administration - U.S. ...
Exhibit 13-1 DRUG-FREE WORKPLACE ACT CERTIFICATION FOR A PUBLIC OR PRIVATE ENTITY 1. The _________________________________________________________________ (Name of Applicant for a Grant or Cooperative Agreement) certifies that it will provide a drug-free workplace by: (a) Publishing a statement notifying employees that the unlawful manufacture, distribution, dispensing, possession, or use of a controlled substance is prohibited in the applicant’s workplace and specifying the actions that will be taken against employees for violation of such prohibition; (b) Establishing an ongoing drug-free awareness program to inform employees about: (1) The dangers of drug abuse in the workplace; (2) The applicant’s policy of maintaining a drug-free workplace; (3) Any available drug counseling, rehabilitation, and employee assistance programs; and (4) The penalties that may be imposed upon employees for drug abuse violations occurring in the workplace. (c) Making it a requirement that each employee be engaged in the performance of the grant or cooperative agreement, and be given a copy of the statement. (d) Notifying the employee in the statement required by paragraph (a) that, as a condition of employment under the grant or cooperative agreement, the employee will: (1) Abide by the terms of the state; and (2) Notify the employer in writing of his or her conviction for a violation of a criminal drug statute occurring in the workplace no later than 5 calendar days after such conviction. (e) Notifying the federal agency in writing, within 10 calendar days after receiving notice under subparagraph (d) (2) from an employee or otherwise receiving actual notice of such conviction. Employers of convicted employees must provide notice, including position title, to every project officer or other designee on whose project activity the convicted employee was working, unless the federal agency has designated a central point for the receipt of such notices. Notice shall include the identification number(s) of each affected grant or cooperative agreement. (f) Taking one of the following actions, within 30 calendar days of receiving notice under subparagraph (d) (2), with respect to any employee who is so convicted of: (1) Taking appropriate personnel action against such an employee, up to and including termination, consistent with the requirements of the Rehabilitation Act of 1973, as amended; or Chapter 13. The Drug-Free Workplace Act of 1988 13-7 August 2002
(2) Requiring such employee to participate satisfactorily in a drug abuse assistance or rehabilitation program approved for such purposes by a federal, state, or local health, law enforcement, or other appropriate agency. (g) Making a good faith effort to continue to maintain a drug-free workplace through implementation of paragraphs (a), (b), (c), (d), (e), and (f). 2. The applicant’s headquarters is located at the following address. The addresses of workplaces maintained by the applicant are provided on an accompanying list. Name of Applicant: Address: City: County: State: Zip code: ______________________________ (Signature of Authorized Official) ______________________________ (Title of Authorized Official) ______________________________ (Name of Applicant) ______________________________ (Date) Chapter 13. The Drug-Free Workplace Act of 1988 13-8 August 2002
- Page 210 and 211: when the applicant was assigned saf
- Page 212 and 213: may arrange to have the consortium
- Page 214 and 215: • Employers and service agents sh
- Page 216 and 217: The list of randomly selected trans
- Page 218 and 219: A. At a Nonprofit Agency or Indepen
- Page 220 and 221: Reporting Period: Laboratory Name a
- Page 222 and 223: Record Retention Checklists (page 2
- Page 224 and 225: Retains CCF1 Split Lab - CCF1 Labor
- Page 226 and 227: CCF1 Split Lab Retains - CCF1 Labor
- Page 228 and 229: U.S. DEPARTMENT OF TRANSPORTATION D
- Page 230 and 231: Chapter 11. CONSORTIA AND THIRD PAR
- Page 232 and 233: Greater Expertise. The FTA and DOT
- Page 234 and 235: Section 2. CONSIDERATIONS IN ESTABL
- Page 236 and 237: esults (≥0.02) between the BAT an
- Page 238 and 239: consideration. Thus, the more diver
- Page 240 and 241: Section 5. IS A CONSORTIUM RIGHT FO
- Page 242 and 243: • Procurement of testing services
- Page 244 and 245: • Consider which consortium model
- Page 246 and 247: Exhibit 11-1 Role of State DOTs in
- Page 248 and 249: Exhibit 11-3 CONSORTIA RESPONSIBILI
- Page 250 and 251: Chapter 12. PROGRAM MONITORING As a
- Page 252 and 253: • Conduct periodic review of serv
- Page 254 and 255: compliance. You are encouraged to c
- Page 256 and 257: Chapter 13. THE DRUG-FREE WORKPLACE
- Page 258 and 259: Violations of the act may result in
- Page 262 and 263: Chapter 14. SUBSTANCE ABUSE MANAGEM
- Page 264 and 265: Notification of audit Requested mat
- Page 266 and 267: them to move throughout the facilit
- Page 268 and 269: above materials. ⎯⎯Procedures t
- Page 270 and 271: DAY 3 Time Activity Team Address of
- Page 272 and 273: Date of Collection Jan-01 Nov-00 Se
- Page 274 and 275: Time of the Test Time of the Test 8
- Page 276 and 277: Each auditor will discuss the porti
- Page 278 and 279: Sample Re-audit Agenda DAY 1 Time A
- Page 280 and 281: Index of Appendices Appendix A. Acr
- Page 282 and 283: AA Alcoholics Anonymous Appendix A.
- Page 284 and 285: RFP Request for Proposal RIA Radio
- Page 286 and 287: Newsletters Appendix B. Additional
- Page 288 and 289: U.S. Department of Labor. What Work
- Page 290 and 291: Other Government Web sites Drug and
- Page 292 and 293: Appendix C Americans with Disabilit
- Page 294 and 295: sensitive duties for the illegal us
- Page 296 and 297: If the individual is qualified and
- Page 298 and 299: allegation of discrimination under
- Page 300 and 301: Appendix D. Certified Laboratories
- Page 302 and 303: DrugProof, Divison of Dynacare 543
- Page 304 and 305: One Source Toxicology Laboratory, I
- Page 306 and 307: The following laboratories are volu
- Page 308 and 309: Federal Register / Vol. 65, No. 141
(2) Requiring such employee to participate satisfactorily in a drug abuse assistance or<br />
rehabilitation program approved for such purposes by a federal, state, or local health,<br />
law enforcement, or other appropriate agency.<br />
(g) Making a good faith effort to continue to maintain a drug-free workplace through<br />
implementation of paragraphs (a), (b), (c), (d), (e), and (f).<br />
2. The applicant’s headquarters is located at the following address. The addresses of workplaces<br />
maintained by the applicant are provided on an accompanying list.<br />
Name of Applicant:<br />
Address:<br />
City:<br />
County:<br />
State:<br />
Zip code:<br />
______________________________<br />
(Signature of Authorized Official)<br />
______________________________<br />
(Title of Authorized Official)<br />
______________________________<br />
(Name of Applicant)<br />
______________________________<br />
(Date)<br />
Chapter 13. The Drug-Free<br />
Workplace Act of 1988<br />
13-8 August 2002
Change language